Zydus gets EIR for injectables manufacturing facility at Zydus Biotech Park
The inspection had concluded with NIL observations
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Eminence Media hosts Cleaning Validation 2023 in Mumbai
This programme addressed critical cleaning validation bottleneck issues
HepaStem seems most promising pipeline agent for decompensated cirrhosis due to NASH: GlobalData
HepaStem is a stem cell therapy consisting of liver-derived mesenchymal stem cells (MSC) that addresses different components of…
JB Pharma publishes its second ESG report for FY 2022-23
JB Pharma reported 19 per cent decrease in GHG intensity as compared to last year
Cracking the code – Generic vs. Brand Medicines
Dr Suresh Saravdekar, Former Assistant Director, Ministry of Medical Education & Research and Honorary Consultant, Institute…
Redx will become a key upcoming player in IPF treatment with FDA’s ODD for zelasudil: GlobalData
KOLs interviewed by GlobalData noted that there is a huge unmet need in the IPF space, which is pushing companies to look for…
Roche presents five-year survival outcomes for Tecentriq plus chemotherapy in ES-SCLC
IMbrella A, an extension of the Phase III IMpower133 study, demonstrates the potential for a durable overall survival benefit with…
Generative AI with Google Lens to detect counterfeits in pharma
Amaninder Singh Dhillon, Consultant explains how combining generative AI and image recognition can help create a more efficient…
BMS mezigdomide, iberdomide to transform multiple myeloma treatment landscape: GlobalData
The sales for mezigdomide and iberdomide are predicted to reach $125 million and $389 million, respectively
Chung-Ang University researchers develop novel DNA biosensor for early diagnosis of cervical cancer
The electrochemical sensor, made of a graphitic nano-onion/molybdenum disulfide nanosheet composite, detects human papillomavirus…
Kiran Mazumdar-Shaw appointed member of Court of Regents at RCSed
The RCSed’s Court of Regents comprises a group of distinguished individuals in their field who provide the College with advice and…
Crohn’s disease treatment market sees major shift with biosimilars and next-gen therapies:…
The recent launch of adalimumab biosimilars not only will cause an overall reduction in the cost of treatment, but also provide…
Lupin partners with Cost Plus Drugs, COPD Foundation
The collaboration seeks to expand availability of Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, to COPD patients in the US…
There has been a strong wave of M&A activity in Indian domestic formulations space
Analysing the increased M&A and investment activity across India’s API, formulations and nutraceutical ingredients, driven by…
Is India capable of ensuring equitable access to biopharmaceuticals?
By introducing cost-effective drugs for critical illness by leveraging path-breaking manufacturing technologies, India could…
Biocon Biologics completes integration of Viatris Biosimilars’ Business in North America
With the completion of the North America integration, the existing commercialised portfolio of biosimilars, Ogiviri…
IndiaRF to acquire API and CRAMS business of Ind-Swift for Rs 1,650 cr
Ind-Swift reported a consolidated revenue of Rs 1,207 crores and consolidated EBITDA of Rs 256 crores in FY23
MHRA approves Pfizer/BioNTech’s adapted COVID-19 vaccine for Omicron XBB.1.5
The vaccine has been approved for use in individuals from six months of age
DCGI issues advisory about Digene Gel following Abbott’s voluntary recall
The advisory instructs healthcare professionals to promptly report any suspicious cases of adverse events linked to this product
Amgen olpasiran may fill critical treatment gap in lowering Lp(a): GlobalData
The latest data from the final analysis of the Phase II OCEAN(a)-DOSE study showed that olpasiran reduced Lp(a) levels in patients…